Catalyst Wire Dossier Catalyst Wire Dossier

Trecondi

treosulfan · medac Gesellschaft für klinische Spezialpräparate mbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Trecondi, covering 2026-02-17 to 2026-02-17. Get the full timeline:

Most recent: EMA Authorised: Trecondi (treosulfan) — medac Gesellschaft für klinische Spezialpräparate mbH

See pricing